Domov › Rak (vse vrste) › Ohio
Klinične študije za Rak (vse vrste) v Ohio
85 študij za Rak (vse vrste) išče udeležence na lokacijah v Ohio.
Mesta v Ohio
- Columbus38 študij
- Cleveland36 študij
- Cincinnati27 študij
- Akron13 študij
- Dayton7 študij
- Toledo6 študij
- Parma3 študij
Uradno besedilo študije (angleško)
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
- GSK Investigational Site, Columbus
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06796907Met Non Small Cell Cancer Registry (MOMENT)
- The Ohio State University Wexner Medical Center, Columbus
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05376891A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
- University Hospitals Cleveland Medical Center /ID# 279601, Cleveland
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 1. okt. 2026 · NCT07024784A Study of ASP3082 in Adults With Advanced Solid Tumors
- Case Western, Cleveland
- Taylor Cancer Research Center, Maumee
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT05382559A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07192471Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Oncology Hematology Care Clinical Trials, LLC, Fairfield
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07566156uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Ohio State University, Columbus
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT05874921Registry Study for Radiation Therapy Outcomes
- University of Cincinnati Medical Center, Cincinnati
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT01255748A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Canton
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06881992A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Dayton Physician's Network, Dayton
Vključevanje udeležencevFaza 3
Starost 18–100 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05920356Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- The Ohio State University, Columbus
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07195591Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- The Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT04981119A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008), Columbus
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06979596A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencev
Starost 15–24 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07223463Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 8, Columbus
Vključevanje udeležencevFaza 3
Starost 18–71 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07504458Pan Tumor Rollover Study
- Oncology Hematology Care, Cincinnati
- The Ohio University, Columbus
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT03899155A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07365241Visugromab in Cachexia International Trial
- Cleveland Clinic Avon Hospital, Avon
- Cleveland Clinic (Main Campus), Cleveland
- Cleveland Clinic Fairview Hospital, Fairview
- in še 1
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07112196TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Cincinnati Medical Center, Cincinnati
- Kettering Health, Kettering
- West Chester Hospital, West Chester
Vključevanje udeležencevFaza 2
Starost 12 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Oncology Hematology Care, Inc., Cincinnati
- University Hospitals of Cleveland, Cleveland
- Cleveland Clinic Foundation, Cleveland
- in še 1
Vključevanje udeležencevFaza 2/3
Vse starosti · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT03435796Collection of Tissue Samples for Cancer Research
- Ohio State University, Columbus
Vključevanje udeležencevOpazovalna študija
2 Months · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT00900198Statins to Prevent Cancer Associated Blood Clots
- Cleveland Clinic Foundation, Cleveland
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07303816A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- GSK Investigational Site, Canton
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07213609Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT05796375RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cleveland Clinic, Cleveland
- The Ohio State University, Department of Psychiatry, Columbus
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07002034A Phase 1/1b Study of IAM1363 in HER2 Cancers
- University Hospital Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06253871Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Miami Valley Hospital South, Centerville
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT05386108A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Miami Valley Hospital South, Centerville
- USO - Oncology Hematology Care, Cincinnati
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- University of Cincinnati, Cincinnati
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06163534Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Gabrail Cancer & Research Center, Canton
- Cleveland Clinic, Cleveland
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06072612Project: Every Child for Younger Patients With Cancer
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- in še 5
Vključevanje udeležencevOpazovalna študija
Do 25 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT02402244A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
- Cleveland Clinic, Cleveland
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT06678659Abatacept in Immune Checkpoint Inhibitor Myocarditis
- Cleveland Clinic, Cleveland
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT05335928FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05919264A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05592626International Rare Brain Tumor Registry
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencevOpazovalna študija
Do 45 let · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT05697874A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Nationwide Children's Hosp, Columbus
Vključevanje udeležencevFaza 2
Starost 1–39 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- OhioHealth O'Bleness Hospital, Athens
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Geauga Hospital, Chardon
- in še 26
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06580314Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
Vključevanje udeležencevFaza 2
Starost 19 in več · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06129747Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT07541365Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.